Marciuch, Anne http://orcid.org/0000-0002-0929-9833
Brenna, Ida Halvorsen
Weimand, Bente
Solli, Kristin Klemmetsby
Tanum, Lars
Røstad, Bente K.
Birkeland, Bente
Funding for this research was provided by:
Norges Forskningsråd (269864)
Helse Sør-Øst RHF (2019105)
Article History
Received: 23 November 2021
Accepted: 29 June 2022
First Online: 18 July 2022
Declarations
:
: Ethical approval for the NaltRec trial, including the present study, was granted by the Norwegian Regional Ethical Committees for Medical and Health Research Ethics (REK) committee South East A (# 2018/132), by the personal data protection representative for each of the sites, and by the Norwegian Medicine Agency (NOMA), EudraCT Code 2017-004706-18. The trial is registered on Clinicaltrials.gov # NCT03647774. It was first registered on Aug 28, 2018, before first participant inclusion on Sep 21, 2018 [CitationRef removed]. All participants gave written, informed consent for their participation.
: All participants gave general written, informed consent for publication, in the consent form of the main NaltRec study. All characteristics, including participants’ names have been anonymized, and the participants have been given fictitious names in the text.
: None.